5 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Inhibitors #AntiPlatelet ... #Inhibitors #Pharmacology ... #Table #Overview ... #Interactions #Pharmacology
Drugs Used in Coronary Artery Disease 
 • Nitrates
 • Ca2+ Channel Blockers
 • Beta-Blockers
 •
Channel Blockers • Beta-Blockers ... Trimetazidine • Antiplatelet ... medications #drugs #pharmacology ... #table
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - ... Pharmacology Comparison ... Table Metoprolol ... #Blockers #Pharmacology ... #Comparison #Table
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... - Summary Table ... anticoagulation in a-fib ... Medications #Summary #Table ... #Pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
to hypertension Antiplatelets ... increased bleed risk Beta-Blockers ... Decreases effects of beta-blockers ... supplementals #herbal #pharmacology ... #DDI #table #cardiology